July 13, 2024

Stem Cell Manufacturing Market Growth Drivers: Exploring Catalysts for Progress

Stem Cell Manufacturing Market

Stem cell manufacturing involves isolation, processing, cryopreservation and banking of stem cells followed by quality testing and characterization. Stem cells hold potential in the field of regenerative medicine given their ability to differentiate into various cell types. Conditions such as cancer, blood disorders, diabetes and neurological diseases damage tissues and organs, which may be repaired using stem cells. This has generated significant demand for stem cell manufacturing technologies among pharmaceutical and biotechnology companies engaged in stem cell research and clinical applications. Stem cell therapies offer advantages over traditional drug-based treatments and surgical interventions by directly regenerating damaged tissues.

The global Stem Cell Manufacturing Market is estimated to be valued at US$ 12.75 billion in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends in the stem cell manufacturing market is the increasing adoption of automated cell processing systems. Automated cell processing systems offer benefits such as reducing manual errors, enhancing cell viability, decreasing processing time and increasing throughput. Major players are focusing on developing automated, closed systems for isolating and processing stem cells. For instance, Terumo BCT develops the Sepax system for automated separation of cord blood stem cells with high viability and yield. Similarly, Hitachi Chemical Advanced Therapeutics Solutions offers CliniMACS Prodigy, an automated clinical-scale cell processing system for isolating various stem cell types from different sources.

Another major trend is outsourcing of stem cell manufacturing processes. Several biopharma companies dealing with stem cell therapies outsource various stem cell manufacturing activities such as cell isolation, expansion and cryopreservation to contract manufacturing organizations owing to their specialized expertise and infrastructure. This helps such companies to focus on drug development while benefiting from cost efficiencies through outsourcing. Increased outsourcing is expected to drive the stem cell manufacturing market growth over the forecast period.

Porter’s Analysis

Threat of new entrants: The stem cell manufacturing market requires substantial investments along with intensive research capability. This creates high entry barriers for new players.

Bargaining power of buyers: The bargaining power of buyers is moderate as demand for stem cell products is increasing but availability and affordability are concerns for buyers.

Bargaining power of suppliers: The bargaining power of suppliers is high as supply of key raw materials like stem cells is limited and suppliers can influence prices.

Threat of new substitutes: The threat of substitutes is low as stem cell therapy is unique with no close substitute. However, gene therapy is an emerging alternative.

Competitive rivalry: The competitive rivalry in the market is high as key players are focusing on increasing their market share through investments in research and development.

Key Takeaways
The global stem cell manufacturing market is expected to witness high growth over the forecast period driven by rising stem cell clinical trials and approvals.

Regional analysis: North America dominates the global market currently owing to the presence of major market players and increasing investments for stem cell R&D in the region. Asia Pacific is expected to witness the fastest growth rate during the forecast period with China and India emerging as major hubs for stem cell research and manufacturing.

Key players: Key players operating in the stem cell manufacturing market are Thermo Fisher Scientific, Merck Group, BD Biosciences, Lonza Group, and Miltenyi Biotec. These players are focusing on enhancing their production capacities and capabilities through strategic collaborations.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it